The core function of the Screening Group (SCR) at IARC is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patients’ quality of life in various settings. These data can then be used to inform and improve the rational use of health-care resources. The Group’s ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (LMICs).

SCR conducts field studies in LMICs to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. These initiatives also address the means by which screening services could be scaled up through local public health services. SCR develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. Through its research programme, SCR generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. The Cancer Screening in 5 Continents (CanScreen5) project of the Group aims to collect information on characteristics and performance of cancer screening programmes around the world and disseminate such information for informed decision making in cancer screening programmes. For example, the Group significantly contributed also to the evaluation of the safety and efficacy of less than three doses of the HPV vaccine in protecting against cervical cancer.

Visitors and news

6th European Roundtable Meeting to Discuss the Quality of Cancer Care, “Improvement of cancer care in low to middle income countries by transfer of knowledge” organized by the German Cancer Society (DKG) and the Union for International Cancer Control (UICC), Berlin, Germany

Dr Partha Basu discussed the knowledge transfer from population research to cancer early detection programmes – IARC experience in the LMICs. He also presented the ‘South-South’ collaboration in knowledge transfer to improve cancer early detection services in the LMICs.

Visit of Dr Usha Rani Reddy Poli, MNJ Institute of Oncology & Regional Cancer Center of Hyderabad, Red Hills, Lakadikapul Hyderabad, India

10/06/2019 – 14/06/2019
Dr Usha Rani visited the Screening Group to work on an analysis and preparation of a new manuscript about self-sampling HPV screening project used in Indian community settings.

New publication: “Breast and Cervical Cancer Screening Program of Morocco: Status of implementation, organization and performance”

The Screening Group in collaboration with Ministry of Health, Kingdom of Morocco and the Lalla Salma Foundation for Cancer Prevention and Treatment, Morocco published this report on the status of implementation, organization and performance of Breast and Cervical Cancer Screening Program of Morocco. The timely publication of the report will inform the policy-makers as the country initiates deliberations to launch the new Cancer Control Programme in the year 2020. View the publication (in French) and read the IARC news.

All visitors and news

Scientific papers

Vale D.B., Filho C.C., Shinzato J.Y., Spreafico F.S., Basu P., Zeferino L.C. Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis. BMC Cancer. 2019 May 10;19(1):432.
PMID: 31077162
Mahajan M., Naik N., Jain K., Patira N., Prasad S., Mogri S., Muwonge R., Lucas E., Faruq F., Sankaranarayanan R., Iyer S., Basu P. Study of Knowledge, Attitudes, and Practices Toward Risk Factors and Early Detection of Noncommunicable Diseases Among Rural Women in India. J Glob Oncol. 2019 Apr;(5):1-10.
PMID: 30998427
Vale D.B.,Sauvaget C., Murillo R., Muwonge R., Zeferino L.C., Sankaranarayanan R. Correlation of Cervical Cancer Mortality with Fertility, Access to Health Care and Socioeconomic Indicators. Rev Bras Ginecol Obstet. 2019 Mar 25.
PMID: 30912091

All scientific papers

IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France - Tel: +33 (0)4 72 73 84 85 - Fax: +33 (0)4 72 73 85 75
© IARC 2019 - All Rights Reserved.